ir.unither

United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting

A pre-specified subgroup analysis from the phase 3 ADVANCE OUTCOMES study showed that ralinepag reduced the risk of clinical worsening in patients with pulmonary arterial hypertension (PAH), ...
ir.unither

Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 19, 2017 /PRNewswire/ -- Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR) is ...
ir.unither

United Therapeutics Announces Successful World’s First UKidney Transplant

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world’s first transplant of a ...
ir.unither

United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the United States District Court for the District of Delaware issued an opinion that finds Liquidia ...
ir.unither

United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 5, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has filed a lawsuit in the U.S. District Court ...
ir.unither

United Therapeutics Repurchases 766,666 Shares of Its Common Stock From Toray Industries

SILVER SPRING, Md., July 27 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that it repurchased an aggregate of 766,666 ...
ir.unither

The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors

SILVER SPRING, Md., Dec. 23 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today the appointment of the Honorable Tommy G ...
ir.unither

United Therapeutics to Announce Second Quarter 2006 Financial Results Before Market Open on Tuesday, August 1, 2006

SILVER SPRING, Md., July 25 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced it would release its second quarter 2006 ...
ir.unither

United Therapeutics Corporation Reports First Quarter 2026 Financial Results

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506844951/en/ ...
ir.unither

United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive ...

Nebulized Tyvaso ® (treprostinil) Inhalation Solution demonstrated superiority over placebo for the change in absolute forced vital capacity by 130.1 mL and reduced the risk of clinical worsening in ...
ir.unither

United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026

ADVANCE OUTCOMES presentations include an analysis showing that ralinepag achieved clinical improvement in a lower risk pulmonary arterial hypertension (PAH) population and reduced clinical worsening ...